ArticleGynecologic oncology2019

Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.

Kumaravel Mohankumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.